A Study of DOXIL/CAELYX in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

NCT02081495 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: DOXIL/CAELYX reference product (Treatment A)
DRUG: DOXIL/CAELYX test product (Treatment B)

Sponsor

Janssen Research & Development, LLC